On June 19th, Gelunhui reported that a shareholder asked PKU Healthcare Corp., Ltd. (000788.SZ) on the investor interaction platform, "Can you introduce the company's synthetic biotechnology or products?" The company responded that it is mainly engaged in the research and development, production, and sales of chemical drug formulations, as well as pharmaceutical circulation and other businesses. The company's pharmaceutical manufacturing sector currently focuses on three major areas: anti-infection, pain relief, and mental health, mainly producing generic drugs. For information on the company's main products, please refer to the annual report disclosed on the Chinalist website and the product introduction on the company's official website.
北大医药(000788.SZ)：医药制造板块目前的产品重点聚焦于抗感染类、镇痛类和精神类三大领域
PKU Healthcare Corp. (000788.SZ)：Currently, the product focus of the pharmaceutical manufacturing sector is on three major areas: anti-infection, analgesia, and mental health.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.